O'Gorman Cedric 4
4 · RELMADA THERAPEUTICS, INC. · Filed May 24, 2023
Insider Transaction Report
Form 4
O'Gorman Cedric
Chief Medical Officer
Transactions
- Purchase
Common Stock
2023-05-23$3.18/sh+10,000$31,800→ 10,121 total
Footnotes (2)
- [F1]The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range.
- [F2]Purchase prices range from $3.135 to $3.2096 per share, inclusive.